Eryilmaz, M. K. Et Al. 2017. Severe periocular bleeding induced by bevacizumab in a patient with recurrent glioblastoma multiforme. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.23, no.5 , 392-395.

Eryilmaz, M. K., Mutlu, H., Musri, F. Y., Salim, D. K., Tazegul, G., & COŞKUN, H. Ş., (2017). Severe periocular bleeding induced by bevacizumab in a patient with recurrent glioblastoma multiforme. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.23, no.5, 392-395.

Eryilmaz, Melek Et Al. "Severe periocular bleeding induced by bevacizumab in a patient with recurrent glioblastoma multiforme," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.23, no.5, 392-395, 2017

Eryilmaz, Melek K. Et Al. "Severe periocular bleeding induced by bevacizumab in a patient with recurrent glioblastoma multiforme." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.23, no.5, pp.392-395, 2017

Eryilmaz, M. K. Et Al. (2017) . "Severe periocular bleeding induced by bevacizumab in a patient with recurrent glioblastoma multiforme." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.23, no.5, pp.392-395.

@article{article, author={Melek K. Eryilmaz Et Al. }, title={Severe periocular bleeding induced by bevacizumab in a patient with recurrent glioblastoma multiforme}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2017, pages={392-395} }